Clinical Trial Update: Phase I Efficacy On Vascular Permeability In Patients With Advanced Colorectal Cancer [Phase 1]

View source ↗

Summary

This Phase I trial by Genzyme evaluated vascular permeability effects in patients with advanced colorectal cancer and has completed, presenting early efficacy r…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Snippet

Sponsor: Genzyme, a Sanofi Company | Conditions: Colorectal Cancer | Phase 1 | Status: COMPLETED